Test Batch of Anti-Viral Drug Favipiravir To Hit Shelves In Russia Next Week

April 7, 2020

MOSCOW, April 7. /TASS/. The first batch of anti-viral drug Favipiravir, which showed good results when tested on novel coronavirus patients in China earlier this year, will appear on the Russian market in about one week, Russian Direct Investment Fund (RDIF) Chief Executive Officer Kirill Dmitriev said.


"Together with the ChemRar Group, we are investing into a medicine that showed excellent results in China, and the first batch will arrive in one week," he said in an interview with Russia’s Channel One on Monday night.

Read More:


Please reload

Featured Posts

BANNED.VIDEO | INFOWARS.COM - Trump Team Produces Massive Evidence Of Election Fraud, Deep State Ordered To Destroy It, FULL SHOW Sunday 11-229-2020

November 30, 2020

Please reload

Recent Posts
Please reload

Please reload

Search By Tags

I'm busy working on my blog posts. Watch this space!

Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square





  • Facebook
  • Twitter
  • LinkedIn

©2018 by Delta News Hub. Proudly created with Wix.com